- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/40 - Two or more oxygen atoms
Patent holdings for IPC class C07D 233/40
Total number of patents in this class: 20
10-year publication summary
|
1
|
4
|
0
|
3
|
2
|
1
|
1
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Massachusetts Institute of Technology | 10254 |
2 |
| King Abdulaziz University | 521 |
2 |
| University of South Alabama | 129 |
2 |
| Novartis AG | 10251 |
1 |
| BASF SE | 21308 |
1 |
| Allergan, Inc. | 2162 |
1 |
| Abide Therapeutics, Inc. | 26 |
1 |
| Akashi Therapeutics, Inc. | 2 |
1 |
| Archroma IP GmbH | 462 |
1 |
| Brown University | 686 |
1 |
| Ionis Pharmaceuticals, Inc. | 956 |
1 |
| Ipsen Pharma S.A.S. | 377 |
1 |
| Rhode Island Hospital | 203 |
1 |
| Shiseido Company, Ltd. | 4255 |
1 |
| TES Pharma S.r.l. | 20 |
1 |
| Vectus Biosystems Limited | 29 |
1 |
| Medivation Prostate Therapeutics LLC | 16 |
1 |
| Other owners | 0 |